Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder

“Selective” serotonin 5-HT2A receptor antagonists

(2022) Austen B. Casey et al.   BIOCHEMICAL PHARMACOLOGY

Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior

(2022) Adam Wojtas et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications

(2022) Orr Shahar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Psilocybin: From Serendipity to Credibility?

(2021) James J. Rucker et al.   Frontiers in Psychiatry

Automated quantification of head-twitch response in mice via ear tag reporter coupled with biphasic detection

(2020) Mario de la Fuente Revenga et al.   JOURNAL OF NEUROSCIENCE METHODS

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

(2020) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice

(2020) Anna U. Odland et al.   BEHAVIOURAL BRAIN RESEARCH

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

(2019) Martin K. Madsen et al.   NEUROPSYCHOPHARMACOLOGY

Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease

(2019) Elena P. Moreno-Jiménez et al.   NATURE MEDICINE

The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation

(2019) Anna U. Odland et al.   NEUROPHARMACOLOGY

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience

(2016) Thomas Pokorny et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

(2016) Anna Rickli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Psychedelics in the treatment of unipolar mood disorders: a systematic review

(2016) James JH Rucker et al.   JOURNAL OF PSYCHOPHARMACOLOGY

LONG-TERM OUTCOME IN ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER

(2013) Michael H. Bloch et al.   DEPRESSION AND ANXIETY

Characterization of the head-twitch response induced by hallucinogens in mice

(2013) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

(2011) Boris B Quednow et al.   NEUROPSYCHOPHARMACOLOGY

Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice

(2009) Liesbeth A. Bruins Slot et al.   BEHAVIOURAL PHARMACOLOGY

Effects ofPsilocybe argentipeson Marble-Burying Behavior in Mice

(2009) Yoshihiro MATSUSHIMA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

(2009) Alexia Thomas et al.   PSYCHOPHARMACOLOGY

Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms

(2008) Nobuaki Egashira et al.   EUROPEAN JOURNAL OF PHARMACOLOGY